Pharmacists in Hines, Illinois
273 Pharmacists found in Hines
Mr. Mark C. Geraci, PHARM.D.
Pharmacist - Oncology
1st Avenue 1 Block North Of Cermak, Building 37 Room 139, Hines, IL 60141
708-786-7866 708-786-7989
Marvin Mccouri Agyeben, PHARMD
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
5000 S 5th Ave, Hines, IL 60141
708-969-1367
Mary Ann Elizabeth Rooney, B.S. PHARMACY
Pharmacist
5th And Roosevelt Road, Hines, IL 60141
708-202-8387 708-202-2011
Dr. Matthew Steven Nelson, PHARMD
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
5000 S 5th Ave, Hines, IL 60141
708-202-3541
May Lo Bewley, BS PHARMACY
Pharmacist
Fifth Ave And Roosevelt, Bldg 37, Cmop, Hines, IL 60141
708-786-7820
Melissa Fontana, PHARMD
Pharmacist - Pharmacotherapy
5000 S 5th Ave, Pharmacy Service (119), Hines, IL 60141
708-202-8387
Melissa Nicole Mcinnis, PHARM.D.
Pharmacist
5000 S 5th Ave, Pharmacy (119), Hines, IL 60141
708-202-8387 708-202-4768
Mr. Michael Leslie Feldman, REGISTERED PHARMACIS
Pharmacist
5th & Roosevelt Rd Building 37 Nw, Hines, IL 60141
708-786-7553
Mr. Michael Kyew Cho, RPH
Pharmacist
5000 S 5th Ave, Bldg 37nw, Hines, IL 60141
708-786-7820 708-786-7980
Mr. Michael Burzic
Pharmacist
1st. Ave 1 Blk N Of Cermak Bldg 37 Rm 139, Department Of Veterans Affairs Pbmeps, Hines, IL 60141
708-786-7973
Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.